Neurones closed at €38.65 recently after a mixed run that includes a 5 year gain and a weaker patch this year, which naturally raises the question of whether that price is supported by the cash the business can generate. With no clear catalyst in the headlines, the key issue for Neurones now is how its recent share performance lines up with the value implied by its future cash flows.
-
Over the past 5 years the stock has returned 27.6%, which puts real weight on whether those gains rest on cash flows that can justify the current level.
-
The company relies on converting its operations into steady free cash flow, which can influence how much room there is for reinvestment, shareholder returns and the timing of those cash flows.
-
What if you looked at Neurones through its earnings instead? See why Neurones's 16.7x P/E tells a different valuation story .
The issue now is whether Neurones' current share price fairly reflects the intrinsic value suggested by its cash flows.
If you want a second reference point while you assess Neurones on its cash flows, it can help to compare it with a focused list built from 193 high quality undervalued stocks .
Does Neurones Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model used here focuses on the cash Neurones can generate for shareholders over time. Latest twelve month free cash flow sits at about €76.1 million, with the model assuming that future cash generation grows from that base rather than shrinking. That growth is set to cool gradually over the coming decade, which fits a more mature business profile instead of a high risk, hyper growth story.
On those assumptions, the DCF points to an intrinsic value that sits substantially above the current share price of €38.65. The valuation hinges on Neurones continuing to convert earnings into solid free cash flow and not needing heavy extra capital to support its operations. If that cash conversion remains consistent, the current market price implies more caution about the future than the model does, which is where the potential upside case comes from. Find out what Neurones could be worth using our Discounted Cash Flow (DCF) estimate .
The Neurones Narrative: What Would Justify Today's Price?
Narratives on Neurones pick up where the DCF leaves off and explain which paths for growth, profitability and earnings would need to occur for the share price to be significantly higher or lower than it is today. Each narrative links its number to a clear view of how Neurones' expansion, cost structure and risk profile might change over time, giving you something specific to revisit as new information appears on Simply Wall St's Community page.
A written, number driven view on Neurones helps pin down exactly what you expect from its growth, margins and execution, so you can test those assumptions as each new result lands. Putting that framework on paper now gives you a clear way to track whether the business is moving closer to or further from the cash flow story implied by today's price.
Share your own Narrative for Neurones and set out the assumptions behind your valuation.
One big piece of the Neurones puzzle is still off the page
Cash flows and share prices only tell part of the story, because the people steering Neurones and the way their pay is structured can heavily influence how that story unfolds. See who runs Neurones and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NRO.PA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
